Chronic Lymphocytic Leukemia Symptoms:

• Several patients are asymptomatic during analysis, apart from a high white blood cell count.
• Few might experience weariness or lymph node swelling or a sense abdominal fullness because of a spleen enlargement.
• As CLL reaches more advanced stages and commences replacing normal bone marrow, the depleted blood counts could lead to one becoming anemic and prone to infections. CLL makes a person more susceptible to infection due to sapped antibodies (gamma globulin) production that posess bacteria-combatant property.
• In 5-10% of the cases, CLL leads to self-annihilation of the patient’s own red blood cells and/or platelets by an ‘autoimmune process’. Platelet obliteration is known as ITP or immune thrombocytopenic purpura and red blood cell annihilation is known as AHA or autoimmune haemolytic anemia.

Diagnosis & Tests:

Chronic lymphocytic leukemia (CLL) is detected by the surge in the white blood cell count comprised chiefly of small lymphocytes. The diagnosis is corroborated by ‘immunophenotyping’ or flow cytometry procedure that reveals coexpression of the CD19 and CD5 markers. CLL is one form of leukemia that has a recognized staging system:

• RAI Stages (0 to I) – In this initial phase of the disease, there is soaring lymphocyte count and swollen lymph nodes.
• RAI Stage II – In this intermediary phase, the spleen shows enlargement.
• RAI Stages (III – IV) – In the final stage of the disease, there is a disturbance in the bone marrow function and a major depletion in the red blood cell and platelet counts.

Among 5-10% of the patients, The CLL could modify to become a belligerent lymphoma known as Richter’s syndrome.

Chronic Lymphocytic Leukemia Treatment:

Majority of the patients having initial-stage chronic lymphocytic leukemia or CLL would not require any form of treatment on diagnosis of the disease. On an average such patients would survive for more than a decade and prompt treatment would not proffer any significant benefits. Treatment is ideally commenced when either a later stage of the disease has been detected or during an intermediary stage with major symptoms, increased lymph node enlargement or a swift rise in the lymphocyte count that is observed to double in less than a year’s time.

Chemotherapy

The most prevalent CLL treatment is the use of the chemotherapy drug fludarabine that is administered intravenously for 5 days in a week during the month prolonging for 4-6 months. Though the schedule for administering fludarabine is quite inopportune, it is known to lead to reticent side effects like weariness. Majority of the patients would respond positively to this form of treatment and continue to exhibit lower levels of the disease for 2-3 years. Chlorambucil, an orally taken chemotherapy drug might additionally be given as a substitute to fludarabine, particularly in older or weak patients.

Trial Treatments

There are numerous new-fangled treatments presently undergoing testing that includes:

• The deployment of other forms of chemotherapy drugs like cyclophos-phamide and Cytoxan merged with fludarabine for observing if this raises the efficacy of the treatment.
• The inclusion of the antibody treatment using rituxirnab (Rituxan).
• The usage of the investigational antibody Campath IH that emerges to be another effectual treatment method.

Additionally, allogeneic stem cell transplantation, additionally known as bone marrow transplantation, could be used as a potential means of curing CLL. This treatment is solely employed for treating the infrequent younger age bracket patients that have belligerent CLL, as majority of the patients having CLL survive that far that the risk of undergoing transplant could rarely be necessary.

The normally functioning white blood cells are powerful infection-combatants. However, among individuals affected with leukemia the irregular white blood cells have a tendency of accumulating, hindering normal white blood cell production and impeding the body’s capacity to combat infection.

Leukemia treatment is a multifarious approach wherein majority of the patients undergo chemotherapy, while others get treated with radiation therapy, BMT or bone marrow implant or biological therapy. In certain circumstances, surgical excision of the spleen would become part of the treatment approach.

The four key forms of leukemia include:

• AML or Acute Myeloid Leukemia – Noticed in both grown-ups and in childhood, this form of leukemia is at times known as ANLL or acute non-lymphocytic leukemia.
• ALL or Acute Lymphoblastic Leukemia – The widely prevalent form of leukemia noted in young children, though also affecting adulthood is inclusive of those in the elderly age bracket of 65 years and above.
• CML or Chronic Myeloid Leukemia – Though chiefly affecting adults, there are rarely few cases of children also observed with CML.
• CLL or Chronic Lymphocytic Leukemia – A condition that is mostly known to inflict older aged individuals past 55 years of age. Though at times, it is noted in the younger age bracket adults and rarest ever cited amongst children.

All leukemia forms can be treated with the right approach and majority of them have a potential of being cured.

Leukemia is categorized on the basis of the rate of proliferation, along with the kind of blood cells it is known to affect. The varied leukemia types widely differ according to their nature and gravity and are pigeonholed into either acute or chronic forms.

• Acute Leukemia – The more belligerent leukemia form that leads to acute symptoms and swiftly progressing to serious medical complications. A dearth of effectual treatment would lead to mortality within time spans of days to weeks.
• Chronic Leukemia – Progresses at a much slothful pace. Some cases do not need to be treated for months or years.

Leukemias additionally are categorized into myeloid or lymphoid forms on the basis of the kind of the white blood cell (WBC) that has been inflicted. Myeloid cells produce neutrophils – a crucial form of WBC that slaughters bacteria. Lymphoid cells produce lymphocytes that safeguard against bacterial germs inclusive of viruses.

Leukemia has been considered by many as a disease inflicting solely children, though approximately ten times as many grown-ups as children are detected with this form of cancer. Newly surfaced leukemia cases have mounted to roughly thirty thousand cases on an annual basis in the U.S.

Leukemia Signs and Symptoms:

AML or acute myeloid leukemia is a widespread form of acute leukemia that accounts to 80% of such cases, noted amongst adults that affects the primal WBC in the bone marrow. AML has 8 varied sub-categories that differ on the basis of treatment, diagnosis and the form of leukemia cell that is entailed. These comprise of:

• M0 – Undifferentiated Leukemia – Classified by the excessive production of extremely primal leukemia cells also called blasts, that are undeveloped to such an extent that at times it is tricky to decipher whether they are AML or ALL cells. This leukemia has a poor diagnosis and accounts for lesser than 5% of AML cases.
• M1 – Acute Myeloblastic Leukemia – This condition accounting for 15-20% of AML cases, is classified by the unwarranted production of very primal WBC or blasts. The bone marrow has in turn, few mature WBC’s.
• M2 – Acute Myeloblastic Leukemia with Maturation – This condition representing 20-30% of  AML cases is classified by the excess production of the primal WBC’s or blasts wherein the bone marrow comprises of full-grown WBC along with the presence of the blasts. A translocation among the 8th and the 21st chromosomes usually takes place and is suggestive of an improved diagnosis.
• M3 – Acute Promyelocytic Leukemia or APL – This leukemia form that can be related to acute bleeding, is classified by the occurrence of abnormal promyelocytes in the bone marrow and peripheral blood. A translocation among the 15th and 17th chromosomes commonly takes place and is suggestive of an enhanced diagnosis. This condition accounts for nearly 10-15% of AML cases.
• M4 -Acute Myelomonocytic Leukemia – This form of leukemia accounting for nearly 20-25% of AML cases is classified by the excessive production of monocytes and myelocytes – the WBC’s that combat contagious agents all over the body.
• M5 – Acute Monocytic Leukemia – The form of leukemia representing 5-10% of AML cases, is classified by the surfeit production of WBC’s, monocytes and monoblasts that are WBC’s which combat contagious agents all through the body.
• M6- Acute Erythroblastic Leukemia – This form of leukemia accounting for fewer than 5% of AML cases is classified by the excessive production of primal red blood cells. This leukemia has a poor diagnosis and mostly is noted to evolve from a condition known as myelodysplasia.
• M7 – Acute Megakaryoblastic Leukemia – Classified by the excess production of primal megakaryocytes that are the cells responsible for giving rise to platelets. This is an atypical form of AML that has an inadequate diagnosis.

Usually the onset of AML is sudden, i.e., in a period of days or weeks. It is not quite often for a patient to be sick for a couple of months. AML causes illness in persons mainly by hindering with the functioning of the normally occurring bone marrow. The offending leukemia cells reinstate and swarm out the normally functioning cells of the bone marrow, thus leading to the sapped blood cell counts. This inadequate number of red blood cells leads to a condition known as anemia that makes an individual feel fatigued and washed out. Dearth if platelets could make one more prone to blood loss and getting bruised, particularly in the skin, nose and gums.

Depleted levels of normal WBC’s raise the chances of infection. Though infections might be of any form, the classical symptoms comprise of:

• Fever.
• Experiencing a runny nose.
• Cough.
• Discomfort and pain in the chest region or breathing distress and shortened gasps.
• Pain experienced during urination
• Occasional diarrhea.

However, highly detrimental are the infections arising in the bloodstream known as sepsis, and pneumonia.